Tuberculosis kills 1.8 million people a year, and 10 million more are infected. Development of host-cell directed therapies that could restore cellular function during M. tuberculosis infection, such as a “release and kill” strategy, could shorten drug treatment of TB patients.
Written by Laura Coulter
Selwyn M. Vickers, M.D., F.A.C.S., senior vice president for Medicine and dean of the UAB School of Medicine, will deliver the annual S. Rexford Kennamer Distinguished Lecture, sponsored by the Montgomery Regional Medical Campus.
Pam Alverson, UAB'S Employee of the Month, maintains a calm, stabilizing presence in a sometimes-overwhelming arena of clinical research.
The expanded UAB Summer Program in Neuroscience, with renewed funding from the National Science Foundation, is looking for underserved undergrads for science mentoring.
UAB’s John Porterfield, a leader in surgical education, has been named to the Board of Directors of the Institute for Surgical Excellence.